![](/img/cover-not-exists.png)
Lapatinib plus paclitaxel versus paclitaxel alone for first line metastatic breast cancer (MBC) in ErbB2+ patients -Quality of Life (QOL) results
Y. Wu, A. Segreti, D. Cella, A. DiLeo, M. Amonkar, M. Koehler, M. Arbushites, M. WalkerVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70722-5
File:
PDF, 56 KB
english, 2008